Antibactrial Activity of Asteriscus graveolens Methanolic Extract: Synergistic Effect with Fungal Mediated Nanoparticles against Some Enteric Bacterial Human Pathogens

Ibtihal Nayel ALrawashdeh,Haitham Qaralleh,Muhamad O. Al-limoun,Khaled M. Khleifat

DOI: https://doi.org/10.48550/arXiv.1911.02245

2019-11-06

Abstract:Antibactrial activity of Asteriscus graveolens methanolic extract and its synergy effect with fungal mediated silver nanoparticles (AgNPs) against some enteric bacterial human pathogen was conducted. Silver nanoparticles were synthesized by the fungal strain namely Tritirachium oryzae W5H as reported early. In this study, MICs of AgNPs against E. aerogenes, Salmonella sp., E. coli and C. albicans in order were 2.13, 19.15, 0.08 and 6.38 micrograms per mL, respectively, while the MICs of A. graveolens ethanolic extract against the same bacteria were 4, 366, 3300 and 40 micrograms per mL, respectively. The MIC values at concentration less than 19.15 and 40 micrograms per mL indicating the potent bacteriostatic effect of AgNPs and A. graveolens ethanolic <a class="link-external link-http" href="http://extract.Increasing" rel="external noopener nofollow">this http URL</a> in IFA was reported when Nitrofurantion and Trimethoprim were combined with Etoh extract with maximum increase in IFA by 6 and 12 folds for, respectively. Also, 10 folds increasing in IFA was reported when trimethoprim was combined with AgNPs: Etoh <a class="link-external link-http" href="http://extract.But" rel="external noopener nofollow">this http URL</a>, there were no synergistic effect between the antifungal agents (Caspofungin and Micafungin) combined with AgNPs and or A. graveolens ethanolic extract against C. <a class="link-external link-http" href="http://albicans.The" rel="external noopener nofollow">this http URL</a> potent synergistic effect of A. graveolens ethanolic extract and/or NPs with the conventional antibiotics is novel in inhibiting antibiotics resistant bacteria. In this study, remarkable increasing in the antibacterial activity, when the most resistant antibiotics combined with A. graveolense thanolic extract and/or NPs was reported.

Quantitative Methods

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: **To study the antibacterial activity of Asteriscus graveolens methanol extract and its combination with fungus - mediated silver nanoparticles (AgNPs) against some intestinal pathogenic bacteria, especially their synergistic effects**. Specifically, the researchers aim to evaluate the broad - spectrum antibacterial activity of these components when used alone and in combination with different antibiotics, and explore their potential in combating multi - drug - resistant bacteria.

### Main research questions include:
1. **Antibacterial activity of Asteriscus graveolens methanol extract and silver nanoparticles (AgNPs)**:
- Evaluate the minimum inhibitory concentration (MIC) of these two substances against specific bacteria (such as Escherichia coli, Enterobacter, Salmonella).

2. **Synergistic effect of silver nanoparticles and Asteriscus graveolens methanol extract**:
- Study whether the combination of the two can enhance the antibacterial effect against the tested bacteria, especially for multi - drug - resistant strains.

3. **Combination therapy of silver nanoparticles, Asteriscus graveolens methanol extract and traditional antibiotics**:
- Explore whether these combinations can improve the antibacterial effect of antibiotics, thereby providing new strategies for treating drug - resistant infections.

### Research background:
- The widespread abuse of antibiotics worldwide has led to the extensive emergence of multi - drug - resistant bacteria, which has become a serious public health problem.
- Silver nanoparticles have attracted attention because of their excellent bactericidal properties, but their application still needs further optimization.
- Asteriscus graveolens is a medicinal plant in the Middle East, and its ethanol extract has shown certain antibacterial activity.

Through this study, the author hopes to find an effective combination therapy to deal with the increasingly serious problem of antibiotic resistance and provide new ideas for the development of future antibacterial drugs.